Shares of Tiziana Life Sciences PLC (LON: TILS) today surged 16.8% after the company revealed plans to spin-off its StemPrintER business in order to unlock its full value.
The new company will be called Accustem Science and will trade on the London Stock Exchange’s standard list with the tentative listing date being towards the end of the fourth quarter. The move will allow Tiziana to focus on its portfolio of clinical diagnostics tools.
On the other hand, the Accustem business will start off with StemPrintER, the breast cancer diagnostic tool, and the SPARE genomics-based personalised medicine division as its main products. The company will also receive approximately £1 million from its parent company as working capital.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Tiziana shareholders will receive one Accustem share for every Tiziana share they own and warrant holders will also receive a similar deal.
Studies have shown that the StemPrintER diagnostic tool is much superior to other tools currently available in the market, hence, splitting the business into a separate company is likely to pay off long-term.
Tiziana share price
Tiziana shares today surged 16.8% to trade at 160p having closed Tuesday’s session trading at 137p.
People who read this also read:
